Literature DB >> 27132033

Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.

Basavaraj N Kallalli1, Kamala Rawson2, Ankur Singh1, Mohammed Arif Awati1, Peeyush Shivhare1.   

Abstract

BACKGROUND: Oral cancer is the commonest cause of death in the Indian population, with a mortality rate of 0.3 million deaths per year. Oral submucous fibrosis (OSMF) is a potentially malignant disorder that has a high prevalence rate in India. It has been found that serum lactate dehydrogenase levels are increased in potentially malignant and malignant disorders. There are very few data on the application of salivary LDH in the detection of such disorders. AIMS AND
OBJECTIVES: The estimation of LDH levels in saliva as diagnostic markers, using a noninvasive method in patients with OSMF, oral cancer, and in the controls.
METHODS: A total of 60 subjects with the age range of 20-70 years were selected from the Department of Oral Medicine &amp; Radiology and were grouped into three groups. Twenty-five subjects with clinically diagnosed OSMF (Group I), 25 subjects with histopathologically diagnosed oral cancer (Group II), and 10 subjects as control (Group III). Five milliliters of unstimulated whole saliva was aseptically collected. Following which, the collected saliva was centrifuged and then analyzed by ERBA-CHEM 5 semi auto-analyzer. The values obtained were statistically analyzed using descriptive statistics and paired t-test using the SPSS software version 22. P-value < 0.05- was taken as significant.
RESULTS: The mean LDH levels were Group I 608.28 ± 30.22, Group II 630.96 ± 39.80, and Group III 182.21 ± 34.85. The P-value obtained was 0.0009 for both Group I and Group II which was highly significant.
CONCLUSION: Salivary LDH levels were consistently higher in OSMF and oral cancer; hence, it could be a future biomarker.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  biomarker; lactate dehydrogenase; oral squamous cell carcinoma; oral submucous fibrosis; potentially malignant disorder; saliva

Mesh:

Substances:

Year:  2016        PMID: 27132033     DOI: 10.1111/jop.12451

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Cyclin G2 Inhibits the Warburg Effect and Tumour Progression by Suppressing LDHA Phosphorylation in Glioma.

Authors:  Sen Li; Jinlan Gao; Xinbin Zhuang; Chenyang Zhao; Xiaoyu Hou; Xuesha Xing; Chen Chen; Qi Liu; Shuang Liu; Yang Luo
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

2.  Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.

Authors:  Abikshyeet Panda; Shyam Sundar Behura; Lipsa Bhuyan; Kailash Chandra Dash; Vijay Kumar; Shirsha Mukherjee
Journal:  J Oral Maxillofac Pathol       Date:  2020-05-08

3.  Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction.

Authors:  Narges Gholizadeh; Maryam Alipanahi Ramandi; Maziar Motiee-Langroudi; Mehrdad Jafari; Hadi Sharouny; Nafiseh Sheykhbahaei
Journal:  BMC Oral Health       Date:  2020-11-10       Impact factor: 2.757

Review 4.  Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.

Authors:  Hui Xu; Feng-Yuan Lyu; Jiang-Yuan Song; Yu-Ming Xu; Er-Hui Jiang; Zheng-Jun Shang; Li-Li Chen; Zhi Xu
Journal:  Biomed Res Int       Date:  2021-03-18       Impact factor: 3.411

Review 5.  Lactate Dehydrogenase Levels in the Saliva of Cigarette and E-Cigarette Smokers (Vapers): A Comparative Analysis.

Authors:  Anitha Krishnan Pandarathodiyil; Anand Ramanathan; Ranjana Garg; Jennifer Geraldine Doss; Fazliny Binti Abd Rahman; Wan Maria Nabillah Ghani; Saman Warnakulasuriya
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

6.  Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.

Authors:  G Anitha; K Vinod Kumar; Gururaj Deshpande; M Nagaraj; Veerbhadra Kalyani
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28

Review 7.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.